Imat 100mg Tablet

Imat 100mg Tablet

Prescription requiredRx Required

Salt Composition: Imatinib

Expiry Date: 01/2028

Special offer

Buy at $8.94

$8.94

Inclusive of all taxes

10 Tablets in Strip

About The Product

Blood Cancer

Description

Imat 100mg tablet is an anti-cancer medication. It is used in the treatment of several types of blood cancer, including Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), and Gastrointestinal Stromal Tumors (GISTs).

The medication's active ingredient is Imatinib, which belongs to the class group of Tyrosine kinase inhibitors. The medicine works by inhibiting he BCR- ABL tyrosine kinase enzyme, which is responsible for the growth of cancer cells in the body.

Dosage and duration is correctly administered by the healthcare professional.

Uses

  • Chronic Myeloid Leukemia (CML),
  • Acute Lymphoblastic Leukemia (ALL)
  • Gastrointestinal Stromal Tumors (GISTs)

Side Effects

Imat 100mg tablet contains various types of side effects, some are recover on their, and some need proper medical attention to treat. Common ones include:

  • Muscle cramps and pain
  • Diarrhea
  • Skin rash, night sweats
  • Tiredness, dizziness
  • Abdominal pain
  • Increased weight
  • Decreased RBC and WBC cells
  • Headache
  • Cough, Inflammation in the nose
  • Fever, lack of sleep

  • Heart failure
  • GI disorders
  • Hypothyroidism
  • Liver failure
  • Swelling in the body
  • Swelling in the face, legs, ankles, and feet
  • Nausea, vomiting

How To Use

  • Doctor suggest to take Imat 100mg tablet with or without food, preferably at the same time every day.
  • Usually, the dose should be taken orally with a whole glass of water.
  • Do not adjust according to your need; always consult a healthcare professional before using the medication to avoid complications during the treatment.

How It Works

Imat 100mg tablet helps control disease progression by inhibiting the BCR- ABL tyrosine kinase enzyme, which is responsible for the uncontrolled growth of cancer cells in the body. By blocking the enzyme, the medicine helps stop the proliferation of malignant cells.

As a result, it stops the cancer cells from spreading to other body parts and prevents the body from further growing tumors in the body.

Safety Advice

Alcohol
Taking Imat 100mg tablet with alcohol may be dangerous to the patient's health, but consult the doctor before taking the medication.
Pregnancy
Imat 100mg tablet is not recommended for pregnant women as it may affect the fetus or newborn. Take guidance from a healthcare expert to ensure safety and precautions.
Breast Feeding
Breastfeeding women should not be advisable for taking Imat 100mg tablet as the medicine is passed through the breast, which somehow affects breast milk. Discuss with the doctor for further queries.
Driving
Imat 100mg tablet may not cause dizziness or sleepiness, but the patient may still experience some side effects. It is important to monitor the response of medication and report any unusual symptoms to the doctor.
Kidney
Kidney patients should take precautions while using Imat 100mg tablet as dose adjustment and doctor's prescription is much needed.
Liver
Imat 100mg tablet is unsafe for liver patients as this may cause common as well as severe side effects. Consult the healthcare supervisor for proper medical attention.

FAQs

Imat 100mg tablet should be used by the patient of Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), and Gastrointestinal Stromal Tumors (GISTs)

References

  • Peng, B., Lloyd, P., & Schran, H. (2005). Clinical pharmacokinetics of imatinib. Clinical pharmacokinetics, 44(9), 879-894. https://pubmed.ncbi.nlm.nih.gov/16122278/
  • Buchdunger, E., O'Reilley, T., & Wood, J. (2002). Pharmacology of imatinib (STI571). European journal of cancer, 38, S28-S36. https://pubmed.ncbi.nlm.nih.gov/12528770/
  • Nikolova, Z., Peng, B., Hubert, M., Seiberling, M., Keller, U., Ho, Y. Y., ... & Capdeville, R. (2004). Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules. Cancer chemotherapy and pharmacology, 53(5), 433-438. https://pubmed.ncbi.nlm.nih.gov/15132131/
  • BOGURADZKI, P. BIOEQUIVALENCE STUDY OF 400 AND 100 MG IMATINIB FILM-COATED TABLETS IN HEALTHY VOLUNTEERS. https://pubmed.ncbi.nlm.nih.gov/25362813/
  • Ma, Z., Zhao, J., Li, S., Gao, F., Zhang, C., Wu, L., & Lin, Y. (2024). Imatinib-induced ulcerative colitis. Journal of Oncology Pharmacy Practice, 30(6), 1111-1117. https://pubmed.ncbi.nlm.nih.gov/38772691/

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Magicine PharmacopyCopyright 2026